Novo Nordisk stock sinks after 2030 growth plan fails to impress investors
- Novo Nordisk: 10 events in the last 90 days
- Previous: earlier the same day · Novo Nordisk stock falls after 2030 strategy disappoints investors
What happened
The Danish drugmaker pledged to launch 5 multi-blockbuster drugs by 2030 and grow revenue in line with peers, but investors wanted more
Summary assembled by rule from the sources below